在急性中风中直接口服抗凝剂的特定逆转剂
Senta Frol1,2, Janja Pretnar Oblak1,2, Mišo Šabovič2,3
1Department of Vascular Neurology, University Medical Center Ljubljana, Ljubljana, Slovenia.
概括
直接口服抗凝剂 (DOAC) 提供了更好的中风预防,但需要特定的逆转药物来治疗急性中风. 这些药物对于DOAC治疗患者的血栓溶解和手术等安全有效的干预措施至关重要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 直接口服抗凝剂 (DOAC) 越来越多地用于预防中风.
- 在接受口服抗凝固 (OAC) 治疗的患者中,DOACs可减少缺血和出血并发症.
- 特定逆转剂的出现为管理DOAC相关并发症提供了新的机会.
研究的目的:
- 讨论针对经过DOAC治疗的急性中风患者的特定逆转剂的优点和担忧.
- 探索这些药物在实现及时治疗干预中的作用.
- 为其临床应用提供跨学科的视角.
主要方法:
- 关于DOAC逆转剂的当前文献的综述.
- 对涉及DOAC用户急性中风的临床情景的分析.
- 对安全性和有效性数据的跨学科讨论.
主要成果:
- 特定的逆转剂可以迅速抵消DOAC的抗凝活动.
- 在诸如静脉血栓溶解 (IVT) 或脑内出血 (ICH) 的神经外科手术等手术之前,有效的逆转是至关重要的.
- 一种理想的药物应该具有最小的安全性问题和立即有效性.
结论:
- 特定的逆转剂对于治疗急性中风的DOAC治疗患者的管理至关重要.
- 它们的可用性提高了关键干预的安全性和有效性.
- 为了最佳的临床实践,需要仔细考虑优势和担忧.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
501
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
501
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
953
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
953
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Anticholinesterase Agents: Poisoning and Treatment
814
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
814


